Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
filingDate |
1995-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2000-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad4ef552f203773f53582ba1f8b0eb45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9297f0233c03dc3cf71b678fc8e1eed4 |
publicationDate |
2000-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0771200-B1 |
titleOfInvention |
Use of raloxifene and its analogs for the manufacture of a medicament for the treatment of viral diseases |
abstract |
A method of inhibiting viral replication comprising administering to a human in need thereof an effective amount of a compound having the formula <IMAGE> (I) wherein R1 and R3 are independently hydrogen, -CH3, <IMAGE> wherein Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof. |
priorityDate |
1994-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |